It was recently estimated that 75% of sessile serrated adenomas with methylate MLH1 are MSI, and progress to mutant BRAF MSI cancers; however, about 25% do not silence the MLH1 gene and become BRAF mutant MSS cancers [178]. The gene discussed is MLH1; the disease is cancer.